Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation.
Nicholas J K BreitbordeEmily K BellCindy WoolvertonJacob G PineHeather WaslterAubrey M MoePublished in: Cost effectiveness and resource allocation : C/E (2021)
Our results highlight the potential cost utility of incorporating MCR within CSC programs for individuals with first-episode psychosis. However, given study limitations, these results should be interpreted cautiously until replicated by large, randomized controlled trials. Trial Registration ClinicalTrials.gov Identifier NCT01570972, registered April 4, 2012, Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT01570972?term=breitborde&draw=2&rank=6 .
Keyphrases
- randomized controlled trial
- escherichia coli
- computed tomography
- study protocol
- public health
- clinical trial
- physical activity
- preterm infants
- image quality
- magnetic resonance imaging
- contrast enhanced
- white matter
- mild cognitive impairment
- systematic review
- human health
- multiple sclerosis
- gestational age
- klebsiella pneumoniae
- positron emission tomography
- risk assessment
- meta analyses
- double blind